Apimeds Pharmaceuticals US (APUS) Amortizatization of Intangibles (2024 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Amortizatization of Intangibles came in at $243177.0 in Q4 2025, up 288.35% YoY from $62618.0 in Q4 2024, and up 24317600.0% on a QoQ basis from $1.0 in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Amortizatization of Intangibles (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 2 years of Amortizatization of Intangibles data on file, last reported at $243177.0 in Q4 2025.
- Quarterly Amortizatization of Intangibles rose 288.35% year-over-year to $243177.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $283010.0 (up 140.41% YoY) and the FY2025 annual result came in at $283010.0, up 140.41% from the prior year.
- Amortizatization of Intangibles rose to $243177.0 in Q4 2025, from $1.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $243177.0 in Q4 2025 to a low of $1.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Apimeds Pharmaceuticals US | 7.35 Mn | 7.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 243,177.00 |
| Dec 31, 2025 | 243,177.00 |
| Sep 30, 2025 | 1.00 |
| Sep 30, 2025 | 1.00 |
| Jun 30, 2025 | 13,056.00 |
| Jun 30, 2025 | 13,056.00 |
| Mar 31, 2025 | 26,776.00 |
| Mar 31, 2025 | 26,776.00 |
| Dec 31, 2024 | 62,618.00 |
| Dec 31, 2024 | 62,618.00 |
| Sep 30, 2024 | 22,530.00 |
| Sep 30, 2024 | 22,530.00 |
| Jun 30, 2024 | 13,619.00 |
| Jun 30, 2024 | 13,619.00 |
| Mar 31, 2024 | 18,952.00 |
| Mar 31, 2024 | 18,952.00 |